ChiCTR2500100860 版本V1.0 版本创建时间2025/04/16 15:08:19 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500100860 

最近更新日期:

Date of Last Refreshed on:

2025-04-16 15:08:03 

注册时间:

Date of Registration:

2025-04-16 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

肌少症老年人运动干预的前瞻性随机对照研究

Public title:

A Prospective Randomized Controlled Study on Exercise Intervention for Sarcopenia in Elderly

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肌少症老年人运动干预的前瞻性随机对照研究

Scientific title:

A Prospective Randomized Controlled Study on Exercise Intervention for Sarcopenia in Elderly

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

梁美华 

研究负责人:

唐慧怡,张晓辉 

Applicant:

Liang Meihua 

Study leader:

Tang Huiyi, Zhang Xiaohui 

申请注册联系人电话:

Applicant telephone:

+86 156 2509 7602

研究负责人电话:

Study leader's telephone:

+86 132 6506 9707

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liangmh987321@163.com

研究负责人电子邮件:

Study leader's E-mail:

584524673@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广州省广州市天河区广州大道中1268号

研究负责人通讯地址:

广州省广州市天河区广州大道中1268号

Applicant address:

1268 Middle Guangzhou Avenue, Tianhe District, Guangzhou, Guangdong, China

Study leader's address:

1268 Middle Guangzhou Avenue, Tianhe District, Guangzhou, Guangdong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广州体育学院

Applicant's institution:

Guangzhou Sport University

研究负责人所在单位:

广州体育学院

Affiliation of the Leader:

Guangzhou Sport University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025LCLL-047

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广州体育学院伦理审查委员会

Name of the ethic committee:

Human Experimental Ethics Inspection of Guangzhou Sport University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-04-01 00:00:00

伦理委员会联系人:

李良鸣

Contact Name of the ethic committee:

Li Liangming

伦理委员会联系地址:

广州省广州市天河区广州大道中1268号

Contact Address of the ethic committee:

1268 Middle Guangzhou Avenue, Tianhe District, Guangzhou, Guangdong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 136 0008 9581

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广州体育学院

Primary sponsor:

Guangzhou Sport University

研究实施负责(组长)单位地址:

广州省广州市天河区广州大道中1268号

Primary sponsor's address:

1268 Guangzhou Avenue, Guangzhou, Guangdong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州体育学院

具体地址:

天河区广州大道中1268号

Institution
hospital:

Guangzhou Sport University

Address:

1268 Middle Guangzhou Avenue, Tianhe District

经费或物资来源:

多中心运动-营养干预促进健康的中国方案 2020YFC2002904

Source(s) of funding:

Multicenter Exercise-Nutrition Intervention for Health Promotion: The China Program 2020YFC2002904

Target disease:

Sarcopenia

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究拟通过多组分训练(抗阻训练/平衡训练/有氧运动/综合方案)、远程监测指导(如可穿戴设备、移动应用APP反馈)、社交化运动干预等多种形式,评估其对社区肌少症患者肌肉功能、活动能力及生活质量的干预效果,为制定个性化康复方案提供科学依据。  

Objectives of Study:

This study aims to evaluate the effects of multi-component training (resistance/balance/aerobic exercise/comprehensive programs), telemonitoring guidance (e.g., wearable devices, mobile app feedback), and socialized exercise interventions on muscle function, mobility, and quality of life in community-dwelling older adults with sarcopenia, thereby providing scientific evidence for developing personalized rehabilitation protocols.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄:60岁及以上社区老年人 2.性别:不限 3.健康状况:经专业评估确诊为肌少症患者(符合亚洲肌少症工作组诊断标准) 5.职业:社区常住居民,无特定职业限制

Inclusion criteria

1. Age: Community-dwelling adults aged >=60 years 2. Gender: No restriction 3. Health Status: Clinically diagnosed with sarcopenia (meeting Asian Working Group for Sarcopenia diagnostic criteria) 4. Occupation: Permanent community residents with no specific occupational restrictions

排除标准:

1. 严重心血管或脑血管疾病 2. 可能影响身体功能评估或训练的骨骼 / 关节疾病 3. 可能影响干预的其他医疗状况 4. 认知障碍(简易精神状态检查评分<24 或临床诊断) 5. 目前正在参与其他干预项目

Exclusion criteria:

1. Severe cardiovascular or cerebrovascular diseases 2. Skeletal/joint disorders that may affect physical function assessment or training 3. Other medical conditions that may interfere with the intervention 4. Cognitive impairment (MMSE score <24 or clinical diagnosis) 5. Currently participating in other intervention programs

研究实施时间:

Study execute time:

From 2025-05-01 00:00:00 To 2027-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-05-01 00:00:00 To 2026-12-01 00:00:00  

干预措施:

Interventions:

组别:

多组分训练方案对肌少症影响(干预组)

样本量:

60

Group:

Effects of Multicomponent Exercise Training on Sarcopenia (Intervention Group)

Sample size:

干预措施:

线下接受系统化结构化的多组分训练方案(抗阻训练/平衡训练/有氧运动)

干预措施代码:

Intervention:

Receive systematic, structured multicomponent exercise training (resistance/balance/aerobic exercises) through in-person sessions.

Intervention code:

组别:

多组分训练方案对肌少症影响(对照组)

样本量:

60

Group:

Effects of Multicomponent Exercise Training on Sarcopenia (Control Group)

Sample size:

干预措施:

线下接受常规社区运动健康指导,不进行系统的多组分训练

干预措施代码:

Intervention:

Receive conventional community-based exercise health guidance in person, without participating in systematic multicomponent training programs.

Intervention code:

组别:

移动应用APP远程居家干预和社区集中干预比较分析(干预组)

样本量:

60

Group:

Comparative Analysis of Remote Home-Based Intervention via Mobile Application Versus Community-Based Group Intervention (Intervention Group)

Sample size:

干预措施:

患者居家完成,通过移动应用APP远程推送运动训练方案和监测运动训练数据

干预措施代码:

Intervention:

Patients complete the intervention at home, receiving remotely delivered exercise training programs and monitoring exercise data through a mobile application.

Intervention code:

组别:

移动应用APP远程居家干预和社区集中干预比较分析(对照组)

样本量:

60

Group:

Comparative Analysis of Remote Home-Based Intervention via Mobile Application Versus Community-Based Group Intervention (Control Group)

Sample size:

干预措施:

在社区活动中心进行相同训练,由专业人士进行现场监督

干预措施代码:

Intervention:

The same training program is conducted at community activity centers under on-site supervision by healthcare professionals.

Intervention code:

组别:

远程居家干预+可穿戴设备实时监测反馈(干预组)

样本量:

60

Group:

Home-based tele-intervention with real-time monitoring and feedback via wearable devices (Intervention Group)

Sample size:

干预措施:

通过移动应用APP推送运动训练方案,患者远程居家观看运动教学视频进行训练,使用可穿戴设备提供实时心率/动作反馈

干预措施代码:

Intervention:

Exercise training programs are delivered via mobile application, with patients remotely following instructional videos at home while receiving real-time heart rate/movement feedback through wearable devices.

Intervention code:

组别:

远程居家干预+可穿戴设备实时监测反馈(对照组)

样本量:

60

Group:

Home-based tele-intervention with real-time monitoring and feedback via wearable devices (Control Group)

Sample size:

干预措施:

通过移动应用APP推送运动训练方案,患者远程居家观看运动教学视频进行训练,相同设备仅记录数据,无反馈功能

干预措施代码:

Intervention:

Exercise training programs are delivered via a mobile application, with patients remotely following instructional videos at home. The same wearable devices are used solely for data recording without feedback functionality.

Intervention code:

组别:

社交化运动干预效果评估(干预组)

样本量:

60

Group:

Evaluation of Socially-Enhanced Exercise Intervention Efficacy (Intervention Group)

Sample size:

干预措施:

移动应用APP推送运动训练方案,患者远程居家观看运动教学视频进行训练,并且通过社群互助组,例如微信小程序打卡,患者互评动作视频,每周排名激励等方式促进患者进行运动训练

干预措施代码:

Intervention:

The mobile application delivers exercise training programs, enabling patients to remotely follow instructional videos at home. Social support components (e.g., WeChat Mini Program check-ins, peer video reviews of exercise form, and weekly performance rankings) are incorporated to enhance exercise adherence.

Intervention code:

组别:

社交化运动干预效果评估(对照组)

样本量:

60

Group:

Evaluation of Socially-Enhanced Exercise Intervention Efficacy (Control Group)

Sample size:

干预措施:

移动应用APP推送运动训练方案,患者远程居家观看运动教学视频进行训练,无社群互助组社交互动,仅自行训练

干预措施代码:

Intervention:

The mobile application delivers exercise training programs, enabling patients to remotely follow instructional videos at home for independent training without social interaction components.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

广州 

Country:

China 

Province:

Guangdong 

City:

Guangzhou 

单位(医院):

广州市疾病控制中心 

单位级别:

无 

Institution
hospital:

Guangzhou Center for Disease Control

Level of the institution:

N/A

测量指标:

Outcomes:

指标中文名:

肌肉力量测试

指标类型:

主要指标

Outcome:

Muscle Strength Assessments

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

身体活动能力测试

指标类型:

主要指标

Outcome:

Physical Function Assessments

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量评估

指标类型:

次要指标

Outcome:

Quality of Life Assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

训练依从性

指标类型:

主要指标

Outcome:

Training Compliance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age 85 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

按区组、性别、年龄分层,随机抽样分组,分为干预组和对照组,分配比例为1:1。随机化序列由研究团队中独立于干预实施和评估的人员负责生成,通过密封信封分配至两组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Participants were stratified by region, sex, and age, then randomly allocated to intervention and control groups with a 1:1 allocation ratio. The randomization sequence was generated by independent personnel not involved in intervention delivery or outcome assessment, with group assignments implemented through sealed opaque envelopes.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

结局评估者和数据分析人员在整个试验过程中对分组情况保持盲态。

Blinding:

Outcome assessors and data analysts remain blinded to group allocation throughout the trial.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Do not share

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

使用病例记录表进行数据收集和管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and management will be conducted using standardized case report forms (CRFs)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-04-16 15:08:03